|
1
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M,
et al: Human microRNA genes are frequently located at fragile sites
and genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar
|
|
8
|
Kida Y and Han YP: MicroRNA expression in
colon adenocarcinoma. JAMA. 299:2628–2629. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sengupta S, den Boon JA, Chen IH, Newton
MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B and
Ahlquist P: MicroRNA 29c is down-regulated in nasopharyngeal
carcinomas, up-regulating mRNAs encoding extracellular matrix
proteins. Proc Natl Acad Sci USA. 105:5874–5878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: miR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF, et al: MiR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu
L, Zhou X, Xie G, Kang T, Wang H, et al: miR-663, a microRNA
targeting p21WAF1/CIP1, promotes the proliferation and
tumorigenesis of nasopharyngeal carcinoma. Oncogene. 31:4421–4433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
naso-pharyngeal carcinoma cells proliferation through
downregulating c-Myc expression. J Cancer Res Clin Oncol.
137:415–422. 2011. View Article : Google Scholar :
|
|
16
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar
|
|
19
|
Busson P, Keryer C, Ooka T and Corbex M:
EBV-associated nasopharyngeal carcinomas: From epidemiology to
virus-targeting strategies. Trends Microbiol. 12:356–360. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu J, Cosmopoulos K, Pegtel M, Hopmans E,
Murray P, Middeldorp J, Shapiro M and Thorley-Lawson DA: A novel
persistence associated EBV miRNA expression profile is disrupted in
neoplasia. PLoS Pathog. 7:e10021932011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barth S, Meister G and Grässer FA:
EBV-encoded miRNAs. Biochim Biophys Acta. 1809:631–640. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xia T, O'Hara A, Araujo I, Barreto J,
Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, et
al: EBV microRNAs in primary lymphomas and targeting of CXCL-11 by
ebv-mir-BHRF1-3. Cancer Res. 68:1436–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nachmani D, Stern-Ginossar N, Sarid R and
Mandelboim O: Diverse herpesvirus microRNAs target the
stress-induced immune ligand MICB to escape recognition by natural
killer cells. Cell Host Microbe. 5:376–385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choy EY, Siu KL, Kok KH, Lung RW, Tsang
CM, To KF, Kwong DL, Tsao SW and Jin DY: An Epstein-Barr
virus-encoded microRNA targets PUMA to promote host cell survival.
J Exp Med. 205:2551–2560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Z, Chen X, Li L, Liu S, Yang L, Ma X,
Tang M, Bode AM, Dong Z, Sun L, et al: EBV encoded miR-BHRF1-1
potentiates viral lytic replication by downregulating host p53 in
nasopharyngeal carcinoma. Int J Biochem Cell Biol. 44:275–279.
2012. View Article : Google Scholar
|
|
27
|
Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao
G and Hayward SD: Modulation of LMP1 protein expression by
EBV-encoded microRNAs. Proc Natl Acad Sci USA. 104:16164–16169.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barth S, Pfuhl T, Mamiani A, Ehses C,
Roemer K, Kremmer E, Jäker C, Höck J, Meister G and Grässer FA:
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the
viral DNA polymerase BALF5. Nucleic Acids Res. 36:666–675. 2008.
View Article : Google Scholar :
|
|
29
|
Lung RWM, Tong JHM, Sung YM, Leung PS, Ng
DCH, Chau SL, Chan AWH, Ng EKO, Lo KW and To KF: Modulation of
LMP2A expression by a newly identified Epstein-Barr virus-encoded
microRNA miR-BART22. Neoplasia. 11:1174–1184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lo AK, Dawson CW, Jin DY and Lo KW: The
pathological roles of BART miRNAs in nasopharyngeal carcinoma. J
Pathol. 227:392–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marquitz AR and Raab-Traub N: The role of
miRNAs and EBV BARTs in NPC. Semin Cancer Biol. 22:166–172. 2012.
View Article : Google Scholar :
|
|
32
|
Chen HC, Chen GH, Chen YH, Liao WL, Liu
CY, Chang KP, Chang YS and Chen SJ: MicroRNA deregulation and
pathway alterations in nasopharyngeal carcinoma. Br J Cancer.
100:1002–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo Z, Zhang L, Li Z, Li X, Li G, Yu H,
Jiang C, Dai Y, Guo X, Xiang J, et al: An in silico analysis of
dynamic changes in microRNA expression profiles in stepwise
development of nasopharyngeal carcinoma. BMC Med Genomics. 5:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei
RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al: Prognostic value of a
microRNA signature in nasopharyngeal carcinoma: A microRNA
expression analysis. Lancet Oncol. 13:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng X, Xiang J, Wu M, Xiong W, Tang H,
Deng M, Li X, Liao Q, Su B, Luo Z, et al: Circulating miR-17,
miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers
in nasopharyngeal carcinoma. PLoS One. 7:e463672012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li T, Chen JX, Fu XP, Yang S, Zhang Z,
Chen KhH and Li Y: microRNA expression profiling of nasopharyngeal
carcinoma. Oncol Rep. 25:1353–1363. 2011.PubMed/NCBI
|
|
37
|
Chen SJ, Chen GH, Chen YH, Liu CY, Chang
KP, Chang YS and Chen HC: Characterization of Epstein-Barr virus
miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One.
5:e127452010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu JY, Pfuhl T, Motsch N, Barth S,
Nicholls J, Grässer F and Meister G: Identification of novel
Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J
Virol. 83:3333–3341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong AM, Kong KL, Tsang JW, Kwong DL and
Guan XY: Profiling of Epstein-Barr virus-encoded microRNAs in
nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Cancer. 118:698–710. 2012. View Article : Google Scholar
|
|
40
|
Cheng AL, Huang WG, Chen ZC, Peng F, Zhang
PF, Li MY, Li F, Li JL, Li C, Yi H, et al: Identification of novel
biomarkers for differentiation and prognosis of nasopharyngeal
carcinoma by laser capture microdissection and proteomic analysis.
Clin Cancer Res. 14:435–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Elefant N, Berger A, Shein H, Hofree M,
Margalit H and Altuvia Y: RepTar: A database of predicted cellular
targets of host and viral miRNAs. Nucleic Acids Res. 39:D188–D194.
2011. View Article : Google Scholar :
|
|
42
|
Maragkakis M, Reczko M, Simossis VA,
Alexiou P, Papadopoulos GL, Dalamagas T, Giannopoulos G, Goumas G,
Koukis E, Kourtis K, et al: DIANA-microT web server: Elucidating
microRNA functions through target prediction. Nucleic Acids Res.
37:W273–W276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang JH, Li JH, Shao P, Zhou H, Chen YQ
and Qu LH: starBase: A database for exploring microRNA-mRNA
interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.
Nucleic Acids Res. 39:D202–D209. 2011. View Article : Google Scholar
|
|
44
|
Kim H, Park S, Min H and Yoon S: vHoT: A
database for predicting interspecies interactions between viral
microRNA and host genomes. Arch Virol. 157:497–501. 2012.
View Article : Google Scholar
|
|
45
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Selbach M, Schwanhäusser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cloonan N, Brown MK, Steptoe AL, Wani S,
Chan WL, Forrest AR, Kolle G, Gabrielli B and Grimmond SM: The
miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle
transition. Genome Biol. 9:R1272008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J,
Xing R, Sun Z and Zheng X: miR-16 family induces cell cycle arrest
by regulating multiple cell cycle genes. Nucleic Acids Res.
36:5391–5404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gusev Y, Schmittgen TD, Lerner M, Postier
R and Brackett D: Computational analysis of biological functions
and pathways collectively targeted by co-expressed microRNAs in
cancer. BMC Bioinformatics. 8(Suppl 7): S162007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chang TC, Wentzel EA, Kent OA,
Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M,
Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53
broadly influences gene expression and promotes apoptosis. Mol
Cell. 26:745–752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dews M, Homayouni A, Yu D, Murphy D,
Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, et
al: Augmentation of tumor angiogenesis by a Myc-activated microRNA
cluster. Nat Genet. 38:1060–1065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
O'Day E and Lal A: MicroRNAs and their
target gene networks in breast cancer. Breast Cancer Res.
12:2012010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lei T, Yuen KS, Xu R, Tsao SW, Chen H, Li
M, Kok KH and Jin DY: Targeting of DICE1 tumor suppressor by
Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal
carcinoma. Int J Cancer. 133:79–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang G, Zong J, Lin S, Verhoeven RJ, Tong
S, Chen Y, Ji M, Cheng W, Tsao SW, Lung M, et al: Circulating
Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers
for nasopharyngeal carcinoma diagnosis and treatment. Int J Cancer.
136:E301–E312. 2015. View Article : Google Scholar
|
|
56
|
Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan
SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, et al: Gene expression
profiling of nasopharyngeal carcinoma reveals the abnormally
regulated Wnt signaling pathway. Hum Pathol. 38:120–133. 2007.
View Article : Google Scholar
|
|
57
|
Meulmeester E and Ten Dijke P: The dynamic
roles of TGF-β in cancer. J Pathol. 223:205–218. 2011. View Article : Google Scholar
|
|
58
|
Chou J, Lin YC, Kim J, You L, Xu Z, He B
and Jablons DM: Nasopharyngeal carcinoma - review of the molecular
mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008.
View Article : Google Scholar : PubMed/NCBI
|
